Last reviewed · How we verify
NCT07007390
Systems Biology of Amyotrophic Lateral Sclerosis (ALS)
trial in ALS in 20 participants. Not yet recruiting.
1 February 2030
Quick facts
| Lead sponsor | Viome |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 1 June 2025 |
| Primary completion | 1 February 2030 |
| Estimated completion | 1 May 2030 |
Conditions studied
- ALS — all drugs for ALS →
- ALS (Amyotrophic Lateral Sclerosis) — all drugs for ALS (Amyotrophic Lateral Sclerosis) →
Sponsor
Viome
Who can join
18 and older, any sex, with ALS or ALS (Amyotrophic Lateral Sclerosis). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to identify molecular features in multiple clinical samples and/or the patient environment that are associated with ALS. Participants will collect biological samples and answer questionnaires regarding their health at each appointment with their ALS practitioner.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07007390
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ALS
Currently open trials in the same condition.
- NCT07460037 — Chinese-Specific Speech Imagery Coding Using High-Density ECoG · NA · recruiting
- NCT07006571 — At-home Treatment With Cortico-spinal tDCS for Amyotrophic Lateral Sclerosis · NA · recruiting
- NCT07193953 — Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS) · Phase 1 · recruiting
- NCT06735014 — Multicenter ALS Imaging Study · recruiting
- NCT06511934 — Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01) · NA · recruiting
Other Viome trials
Trials by the same sponsor.
- NCT06190184 — Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions · NA · unknown
- NCT05972330 — Efficacy of VRx MyBiotics Oral Lozenges · NA · completed
- NCT05579444 — Systems Biology of Gastrointestinal and Related Diseases · terminated
- NCT05465616 — Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c · NA · recruiting
- NCT05383326 — Longitudinal Analysis of the Vaginal Microbiome · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07007390 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Viome
- Last refreshed: 5 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07007390.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing